Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Novel Intracanalicular Insertion Device for DEXTENZA in Healthy Subjects
NCT04945824Phase 1Terminated
- Sponsor
- Ocular Therapeutix
- Start
- Jun 2021
- Primary completion
- Nov 2022
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial, sponsored by Ocular Therapeutix. Primary endpoint: Ease of insertion as assessed by Post-Insertion Investigator Questionnaire at Day 1. Started Jun 2021; status: terminated.
Beyond the preview
Go deeper on NCT04945824.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04945824.